Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Lung 97 (1942), S. 534-536 
    ISSN: 1432-1750
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    [S.l.] : American Institute of Physics (AIP)
    Journal of Applied Physics 62 (1987), S. 3522-3534 
    ISSN: 1089-7550
    Source: AIP Digital Archive
    Topics: Physics
    Notes: Diode experiments on the PBFA-I pulser using a magnetically insulated ion diode are described. The insulating magnetic field is supplied by self-field due to the ion current plus the field generated by a series field coil. In the experiments described here, the diode operated at the 10-TW, 2.5-MV level with over 300 kJ going to the diode on many shots. The operation of the diode, the dielectric anode, and the proton beam focusing are described.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Nuclear Inst. and Methods in Physics Research, B 55 (1991), S. 782-784 
    ISSN: 0168-583X
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Physics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Tetrahedron 30 (1974), S. 3799-3805 
    ISSN: 0040-4020
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Tetrahedron 46 (1990), S. 1235-1252 
    ISSN: 0040-4020
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 0040-4020
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    Monatsschrift Kinderheilkunde 148 (2000), S. 242-245 
    ISSN: 1433-0474
    Keywords: Schlüsselwörter ; Säuglingsbotulismus ; Clostridium botulinum ; Floppy-infant-Syndrom ; SIDS ; Key words ; Infant botulism ; Clostridium botulinum ; Floppy-infant-syndrome ; SIDS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary Background: Infant botulism was first diagnosed in California in 1976 and was frequently observed in the USA since that time. Only a few reports have been published about this disease in Europe since 1993. Patient: An Infant 3 1/2-month of age fell ill with constipation, dysphagia, paralysis of ophthalmic and respiratory muscles, paralysis of all voluntary muscles and bradycardia. Botulinal toxin typ A was identified in the stool and in the serum. C. botulinum could be cultivated in the stool. The toxin is pro- duced In the intestine of the young infant and paralyses the neuromuscular junction irreversiblely. Conclusions: The severity of illness requires an intensive care in time. Honey can be contaminated with spores of C. botulinum and should not be fed to small infants.
    Notes: Zusammenfassung Hintergrund: Der Säuglingsbotulismus wurde 1976 in Kalifornien erstmalig diagnostiziert und seither in Amerika häufig beobachtet. In Europa ist die Erkrankung selten. Patient: Ein 3 1/2 Monate alter Säugling erkrankte mit Obstipation, Schluckstörung, Augenmuskellähmung, schlaffer Lähmung der gesamten Willkürmuskulatur, Atemmuskellähmung und Bradykardie. Im Stuhl und im Serum wurde Botulinumtoxin Typ A nachgewiesen. Aus dem Darminhalt konnte Clostridium botulinum angezüchtet werden. Das Toxin wurde im Darm des jungen Säuglings gebildet und hemmte irreversibel die neuromuskuläre Erregungsübertragung. Schlußfolgerungen: Die Schwere der Erkrankung erfordert einen rechtzeitigen und großzügigen Einsatz der Intensivtherapie. Honig kann mit Clostridium botulinum-Sporen kontaminiert sein und sollte in der Säuglingsernährung keine Verwendung finden.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    ISSN: 1433-0474
    Keywords: Schlüsselwörter Lyme Borreliose ; Verschiedene Formen ; Kindesalter ; Diagnostik ; Therapie ; Key words Lyme disease ; Different forms ; Childhood ; Diagnosis ; Therapy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract Lyme borreliosis is the most frequent tick-borne disease of man in the Northern Hemisphere. A variety of systems may be involved. The most frequent manifestations in childhood include erythema migrans, meningitis, cranial nerve palsy and arthritis. Erythema migrans is usually easily recognized and determination of antibodies to Borrelia burgdorferi should not be performed. Childhood neuroborreliosis is characterized mostly by aseptic meningitis with or without cranial nerve palsy, in most cases facial palsy. Basic CSF findings often show combined evidence of lymphocytic pleocytosis, IgM-class dominance in intrathecal humoral immune response, and blood-CSF barrier dysfunction. Calculation of the B. burgdorferi-specific antibody index (according to Reiber) has proved to be the most sensitive method for detecting intrathecal synthesis of specific antibodies. Lyme arthritis presents initially as episodic oligoarthritis, mostly involving the knee joint, and may turn into chronic monoarthritis of the knee; usually high titers of IgG antibodies to B. burgdorferi are found. Rarer manifestations such as encephalomyelitis, chronic arthritis, carditis and inflammatory eye disease may be difficult to diagnose due to clinical ambiguity and problems in the interpretation of serological results. Antibodies to B. burgdorferi found by the sensitive Elisa test must always be confirmed by immunoblot analysis, but sometimes immunoblot analysis is more sensitive than the Elisa. Treatment is by antibiotics, amoxicillin for erythema migrans, and i. v. third-generation cephalosporins for all other manifestations. Discussion: Even after successful antibiotic therapy, antibodies may persist for months and years, and no further antibiotic treatment is necessary in the absence of attributable clinical manifestations. The differentiation between a persisting immune response and a persisting infection therefore has to be based upon the clinical symptoms, non-specific laboratory data and the development of antibody titers.
    Notes: Zusammenfassung Hintergrund: Die Lyme-Borreliose ist die häufigste durch infizierte Zecken übertragene Infektionskrankheit des Menschen in Europa. Erscheinungsformen: Verschiedene klinische Erscheinungsformen können auftreten. Die Krankheitsbilder Erythema migrans, Meningitis, Hirnnervenlähmung und Arthritis dominieren im Kindesalter. Das Erythema migrans ist gewöhnlich leicht diagnostizierbar und eine Antikörperbestimmung ist nicht indiziert. Die Neuroborreliose manifestiert sich meist als eine seröse Meningitis mit oder ohne Hirnnervenparese, hauptsächlich periphere Fazialisparese. Der Liquorbefund bietet häufig das gleichzeitige Vorliegen von lymphozytärer Pleozytose, IgM-Dominanz in der intrathekalen Immunantwort und eine Schrankenstörung. Serodiagnostisch ist die Bestimmung des spezifischen Antikörperindex nach Reiber der beste Parameter zum Nachweis einer intrathekalen, erregerspezifischen Antikörperbildung. Die Lyme-Arthritis imponiert anfangs als episodische Oligoarthritis, meist unter Einschluß des Kniegelenks, und kann in eine chronische Monarthritis des Knies übergehen. Fast immer werden hohe IgG-Antikörper-Titer gefunden. Die seltenen Manifestationen Enzephalomyelitis, chronische Arthritis, Karditis und entzündliche Augenerkrankungen sind klinisch vieldeutig, bieten selten eindeutige Befunde und sind in der Interpretation der serologischen Ergebnisse problematisch. Die Spezifität der durch ELISA oder IFT ermittelten Antikörper muß im Immunoblot bewiesen werden. Diskussion: Therapeutisch sind Amoxicillin oder Doxicyclin beim Erythma migrans und Zephalosporine der 3. Generation parenteral bei den übrigen Manifestationen als Mittel der Wahl anzusehen. Trotz klinisch erfolgreicher antibiotischer Therapie können sowohl die IgM- als auch die IgG-Antikörpertiter über Monate und Jahre persistieren, ohne daß sich daraus eine neue Behandlungsindikation ergibt, wenn nicht gleichzeitig noch eine weitere klinische Symptomatik besteht. Die Unterscheidung zwischen einer persistierenden Infektion und einer Seronarbe kann nur unter Berücksichtigung der klinischen Symptomatik, unspezifischen Laborparametern und Antikörpertitern im Verlauf getroffen werden.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical microbiology & infectious diseases 17 (1998), S. 470-478 
    ISSN: 1435-4373
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract  Erythromycin is frequently prescribed in Germany for acute otitis media, but well-designed clinical trials under present epidemiological conditions are lacking. Therefore, a double-blind, randomized, multicenter trial was performed to compare the clinical efficacy and safety of erythromycin estolate versus amoxicillin in children with acute otitis media and to identify the risk factors associated with clinical failure. Investigators from 19 centers throughout Germany recruited 302 children with clinical, otoscopic, and tympanometric evidence of acute otitis media. In a double-blind fashion, patients were allocated randomly to a 10-day course of erythromycin estolate at 40 mg/kg/day in two divided doses or amoxicillin at 50 mg/kg/day in two divided doses. Clinical examinations, otoscopy, and tympanometry were performed at baseline, day 3–5, day 9–11, and at 5 weeks. Clinical outcome was assessed on day 9–11. Two-hundred eighty children were evaluable for efficacy (erythromycin group, 141; amoxicillin group, 139). Both groups were comparable with respect to demographic data and severity of disease at entry. Treatment was successful in 94% of the erythromycin-treated patients and in 96% of the amoxicillin-treated patients. Clinical outcome was statistically equivalent between groups within a range of 7 percentage points. Clinical recurrence was seen in eight erythromycin-treated children (5.7%) and in seven amoxicillin-treated children (5.0%) (P=0.81). Patients with bilateral disease at entry were at higher risk of unfavourable outcome, whereas age and presence/absence of otorrhea at entry were not associated with outcome. Treatment-related adverse events were recorded in eight (5.3%) of 151 erythromycin-treated patients and in 11 (7.3%) of 151 amoxicillin-treated patients. In this study in an outpatient setting in Germany, erythromycin estolate was as safe and effective as amoxicillin in the treatment of acute otitis media. Both drugs can be administered in a convenient twice-daily dosage schedule.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical microbiology & infectious diseases 17 (1998), S. 470-478 
    ISSN: 1435-4373
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Erythromycin is frequently prescribed in Germany for acute otitis media, but well-designed clinical trials under present epidemiological conditions are lacking. Therefore, a double-blind, randomized, multicenter trial was performed to compare the clinical efficacy and safety of erythromycin estolate versus amoxicillin in children with acute otitis media and to identify the risk factors associated with clinical failure. Investigators from 19 centers throughout Germany recruited 302 children with clinical, otoscopic, and tympanometric evidence of acute otitis media. In a double-blind fashion, patients were allocated randomly to a 10-day course of erythromycin estolate at 40 mg/kg/day in two divided doses or amoxicillin at 50 mg/kg/day in two divided doses. Clinical examinations, otoscopy, and tympanometry were performed at baseline, day 3–5, day 9–11, and at 5 weeks. Clinical outcome was assessed on day 9–11. Two-hundred eighty children were evaluable for efficacy (erythromycin group, 141; amoxicillin group, 139). Both groups were comparable with respect to demographic data and severity of disease at entry. Treatment was successful in 94% of the erythromycin-treated patients and in 96% of the amoxicillin-treated patients. Clinical outcome was statistically equivalent between groups within a range of 7 percentage points. Clinical recurrence was seen in eight erythromycin-treated children (5.7%) and in seven amoxicillin-treated children (5.0%) (P=0.81). Patients with bilateral disease at entry were at higher risk of unfavourable outcome, whereas age and presence/absence of otorrhea at entry were not associated with outcome. Treatment-related adverse events were recorded in eight (5.3%) of 151 erythromycin-treated patients and in 11 (7.3%) of 151 amoxicillin-treated patients. In this study in an outpatient setting in Germany, erythromycin estolate was as safe and effective as amoxicillin in the treatment of acute otitis media. Both drugs can be administered in a convenient twice-daily dosage schedule.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...